Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Parainfluenzae Virus Infection”

7 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 7 of 7 results

Large-scale testing (Phase 3)Looking for participantsNCT03808922
What this trial is testing

Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study

Who this might be right for
Lower Respiratory Tract InfectionParainfluenzaImmunocompromised+1 more
Ansun Biopharma, Inc. 274
Testing effectiveness (Phase 2)Study completedNCT01644877
What this trial is testing

A Phase II, Randomized, Double-blind, Placebo-controlled Study to Examine the Effects of DAS181 in Immunocompromised Subjects With Lower Respiratory Tract Parainfluenza Infection on Supplemental Oxygen

Who this might be right for
Parainfluenza
Ansun Biopharma, Inc. 111
Not applicableEnded earlyNCT04431050
What this trial is testing

Evaluation of a Single Use Point of Care Device for the Diagnosis of Respiratory Pathogens

Who this might be right for
Human InfluenzaRespiratory Syncytial Virus InfectionsRhinoviral Infections+3 more
Imperial College London 6
Early research (Phase 1)Study completedNCT03392389
What this trial is testing

Safety, Reactogenicity, and Immunogenicity of mRNA-1653 in Healthy Adults

Who this might be right for
Human Metapneumovirus and Human Parainfluenza Infection
ModernaTX, Inc. 124
Testing effectiveness (Phase 2)WithdrawnNCT01441024
What this trial is testing

DAS181 in Patients With Parainfluenza

Who this might be right for
Parainfluenza Infection
National Institute of Allergy and Infectious Diseases (NIAID)
Early research (Phase 1)Active Not RecruitingNCT06604767
What this trial is testing

Study of a Respiratory Syncytial Virus/Human Metapneumovirus/Parainfluenza Virus Type 3 Vaccine Candidate in Adults Aged 60 Years and Older

Who this might be right for
Respiratory Syncytial Virus InfectionMetapneumovirus InfectionParainfluenzae Virus Infection
Sanofi Pasteur, a Sanofi Company 390
Early research (Phase 1)Study completedNCT04144348
What this trial is testing

Safety and Immunogenicity of mRNA-1653, a Combined Human Metapneumovirus (hMPV) and Parainfluenza Virus Type 3 (PIV3) Vaccine, in Healthy Adults, and Children 12 to 59 Months of Age With Serologic Evidence of Prior Exposure

Who this might be right for
Human Metapneumovirus and Human Parainfluenza Infection
ModernaTX, Inc. 51